Global Antinuclear Antibody Test Market 2022-2028

Description

List of Tables

Global Antinuclear Antibody (ANA) Test Market Size, Share & Trends Analysis Report by Product Type (Assay Kits & Reagents, Antinuclear Antibody Test System, and Antinuclear Antibody Test Software), by Test Type (Indirect Immunofluorescence, Enzyme-Linked Immunosorbent Assay (ELISA), and Multiplex Testing), by Disease Type (Systemic Lupus Erythematosus, Sjogren's Syndrome, Rheumatoid Arthritis, Scleroderma, and Others), and by End-User (Hospitals and Clinical Laboratories) Forecast Period (2022-2028)

The global ANA Test market is anticipated to grow at a substantial CAGR of 12.3% during the forecast period. The increasing demand for advanced test kits and the increase in healthcare expenditure in emerging economies are expected to create opportunities for the market during the forecast period. However, the lack of regulatory policies for the approval of drugs and the lack of skilled medical professionals are the factors that are restraining the manufacturing of test kits. The high cost of antinuclear antibody tests restrains its adoption in middle-income groups.

The global ANA Test market is segmented based on product type, test type, disease type, and end-user. Based on the product type, the market is segmented into assay kits & reagents, antinuclear antibody test systems, and antinuclear antibody test software. Based on the test type, the market is sub-segmented into indirect immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and multiplex testing. Based on the disease type, the market is augmented into systemic lupus erythematosus, sjogren's syndrome, rheumatoid arthritis, scleroderma, and others. Based on the end-user, the market is bifurcated into hospitals and clinical laboratories. The above-mentioned segments can be customized as per the requirements.Among the disease type, Sjogren's syndrome is expected to fuel the segment growth over the forecast period. With this disorder, the body's immune system attacks its healthy cells that produce saliva and tears. Sjogren's syndrome often occurs with other such disorders, such as rheumatoid arthritis and lupus.

Geographically the global ANA Testmarket is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Among all regions, the North American region is expected to hold a remarkable market share in the market over the forecast period. High reimbursement policies by the government in the healthcare sector and the sedentary lifestyle of the population are significantly contributing to the market growth in the region. For instance, according to the National Health Expenditure Accounts (NHEA), in the US health care spending rose to 4.6% in 2019, which is around $11,852 per person.

The major companies serving the global ANA Testmarket include Abbott Laboratories,AESKU.GROUP GmbH, Antibodies Inc., Bio-Rad Laboratories, Inc., Hycor Biomedical, MBL International Corp., Thermo Fisher Scientific Inc., ZEUS Scientific, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2021, the company announced the launch of the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Company's well-established EUROLabOffice 4.0 (ELO 4.0) laboratory management software. The combined system of hardware and software allows for ultrafast automated immunofluorescence image acquisition, pattern recognition, and titer estimation as well as modern diagnostics at the screen.

Research Methodology

The market study of the global ANA testmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, andintended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global ANA Test Market Research and Analysis by Product Type.

2. Global ANA Test Market Research and Analysis by Test Type.

3. Global ANA Test Market Research and Analysis by Disease Type.

4. Global ANA Test Market Research and Analysis by End-User.

The Report Covers

Comprehensive research methodology of the global ANA testmarket.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global ANA test market.
Insights about market determinants that are stimulating the global ANA Test market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2018286

Category- Biotechnology

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global ANA Test Market
Recovery Scenario of Global ANA Test Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. ByRegion

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

4.1. Global ANA Test Market by Product Type
- 4.1.1. Assay Kits & Reagents
- 4.1.2. Antinuclear Antibody Test System
- 4.1.3. Antinuclear Antibody Test Software
4.2. Global ANA Test Market by Test Type
- 4.2.1. Indirect Immunofluorescence
- 4.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 4.2.3. Multiplex TestingGlobalANA Test Market by Disease Type
4.3. Global ANA Test Market by Disease Type
- 4.3.1. Systemic Lupus Erythematosus
- 4.3.2. Sjogren's Syndrome
- 4.3.3. Rheumatoid Arthritis
- 4.3.4. Scleroderma
- 4.3.5. Others (Addison Disease And Pulmonary Fibrosis, Polymyositis)
4.4. Global ANA Test Market by End-User
- 4.4.1. Hospitals
- 4.4.2. Clinical Laboratories

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Abbott Laboratories
6.2. Abcam Plc.
6.3. AESKU.GROUP GmbH
6.4. American Laboratory Products Company (ALPCO)
6.5. AMS S.r.l
6.6. Antibodies Inc.
6.7. Aviva Systems Biology Corp.
6.8. BIOCOM Africa Pty Ltd.
6.9. Bio-Rad Laboratories, Inc.
6.10. ELITechGroup
6.11. Erba Mannheim
6.12. EUROIMMUN MedizinischeLabordiagnostika AG
6.13. Hycor Biomedical
6.14. Immuno Concepts Ltd.
6.15. MBL International Corp.
6.16. Merck KGaA
6.17. Meridian Bioscience, Inc.
6.18. Quest Diagnostics
6.19. Thermo Fisher Scientific Inc.
6.20. True Health Labs
6.21. Wiener Laboratorios SAIC
6.22. Werfen
6.23. ZEUS Scientific, Inc.